Publications

Shimberg, WR, NB Patel, KL Sullivan, RA Hauser, and TA Zesiewicz. 2008. “Levetiracetam for Stiff-Person Syndrome: Report of 2 Patients”. Clin Neuropharmacol.

Brin, MF, CL Comella, J Jankovic, F Lai, M Naumann, and BoNTA Study Group. 2008. “Long-Term Treatment With Botulinum Toxin Type A in Cervical Dystonia Has Low Immunogenicity by Mouse Protection Assay.”. Mov Disord.

Simon, DK, CJ Swearingen, RA Hauser, JM Trugman, MJ Aminoff, C Singer, D Truong, and BC Tilley. 2008. “Caffeine and Progression of Parkinson Disease.”. Clin Neuropharmacol.

Schwarzschild, MA, SR Schwid, K Marek, A Watts, AE Lang, D Oakes, I Shoulson, A Ascherio, The Parkinson Study Group QE3 Investigators, and . 2008. “Serum Urate As a Predictor of Clinical and Radiographic Progression in Parkinson Disease.”. Arch Neurol.

Investigators, The NINDS NET-PD, and RA Hauser. 2008. “A Pilot Clinical Trial of Creatine and Minocycline in Early Parkinson Disease: 18-Month Results”. Clin Neuropharmacol.

Encarnacion, EV, and RA Hauser. 2008. “Levodopa-Induced Dyskinesias in Parkinson’s Disease: Etiology, Impact on Quality of Life, and Treatments”. Eur Neurol.

Kordower, JH, Y Chu, RA Hauser, TB Freeman, and CW Olanow. 2008. “Lewy Body-Like Pathology in Long-Term Embryonic Nigral Transplants in Parkinson’s Disease”. Nat Med.

Zesiewicz, TA, WR Shimberg, RA Hauser, W Robinson, MC Wilson, and KL Sullivan. 2008. “Chorea As a Side Effect of Gabapentin (Neurontin) in a Patient With Complex Regional Pain Syndrome Type 1”. Clin Rheumatol.

Zesiewicz, TA, KL Sullivan, M Hoffman, LM Benes, DA Smith, CL Ward, and RA Hauser. 2008. “Delayed Thalamic Intracranial Hemorrhage in an Essential Tremor Patient Following Deep Brain Stimulation”. Eur Neurol.

Goetz, CG, J Wuu, MP McDermott, CH Adler, S Fahn, CR Freed, RA Hauser, et al. 2008. “Placebo Response in Parkinson’s Disease: Comparisons Among 11 Trials Covering Medical and Surgical Interventions”. Mov Disord.